These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 18561090)

  • 1. Increased expression levels of tensin3 mRNA in thyroid functional adenomas as compared to non-functioning adenomas.
    Maeda I; Yamada H; Takano T; Nishihara E; Ito Y; Matsuzuka F; Miya A; Kobayashi K; Yoshida H; Miyauchi A; Hidaka Y
    Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):191-3. PubMed ID: 18561090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tensin3 is a novel thyroid-specific gene.
    Maeda I; Takano T; Yoshida H; Matsuzuka F; Amino N; Miyauchi A
    J Mol Endocrinol; 2006 Feb; 36(1):R1-8. PubMed ID: 16461921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tensin3 is a negative regulator of cell migration and all four Tensin family members are downregulated in human kidney cancer.
    Martuszewska D; Ljungberg B; Johansson M; Landberg G; Oslakovic C; Dahlbäck B; Hafizi S
    PLoS One; 2009; 4(2):e4350. PubMed ID: 19194507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor modulates tyrosine phosphorylation of a novel tensin family member, tensin3.
    Cui Y; Liao YC; Lo SH
    Mol Cancer Res; 2004 Apr; 2(4):225-32. PubMed ID: 15140944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid screening of specific changes in mRNA in thyroid carcinomas by sequence specific-differential display: decreased expression of acid ceramidase mRNA in malignant and benign thyroid tumors.
    Maeda I; Takano T; Matsuzuka F; Maruyama T; Higashiyama T; Liu G; Kuma K; Amino N
    Int J Cancer; 1999 May; 81(5):700-4. PubMed ID: 10328219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-3 and oncofetal-fibronectin expression in thyroid neoplasia as assessed by reverse transcription-polymerase chain reaction and immunochemistry in cytologic and pathologic specimens.
    Giannini R; Faviana P; Cavinato T; Elisei R; Pacini F; Berti P; Fontanini G; Ugolini C; Camacci T; De Ieso K; Miccoli P; Pinchera A; Basolo F
    Thyroid; 2003 Aug; 13(8):765-70. PubMed ID: 14558920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of the expression of oncofetal fibronectin mRNA in thyroid carcinomas by competitive reverse transcription-polymerase chain reaction.
    Higashiyama T; Takano T; Matsuzuka F; Liu G; Miyauchi A; Yokozawa T; Morita S; Kuma K; Shiba E; Noguchi S; Amino N
    Thyroid; 1999 Mar; 9(3):235-40. PubMed ID: 10211598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural protein kinase C alpha mutant is present in human thyroid neoplasms.
    Prévostel C; Alvaro V; de Boisvilliers F; Martin A; Jaffiol C; Joubert D
    Oncogene; 1995 Aug; 11(4):669-74. PubMed ID: 7651730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulated alternative splicing of CD44 messenger RNA transcripts in neoplastic and nonneoplastic lesions of the human thyroid.
    Ermak G; Gerasimov G; Troshina K; Jennings T; Robinson L; Ross JS; Figge J
    Cancer Res; 1995 Oct; 55(20):4594-8. PubMed ID: 7553635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitous expression of galectin-3 mRNA in benign and malignant thyroid tumors.
    Takano T; Miyauchi A; Matsuzuka F; Yoshida H; Kuma K; Amino N
    Cancer Lett; 2003 Sep; 199(1):69-73. PubMed ID: 12963125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of follicular thyroid tumors by molecular signature: results of gene profiling.
    Barden CB; Shister KW; Zhu B; Guiter G; Greenblatt DY; Zeiger MA; Fahey TJ
    Clin Cancer Res; 2003 May; 9(5):1792-800. PubMed ID: 12738736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterisation of human cells harbouring a novel t(2p;7p) translocation involving TNS3 and EXOC6B genes.
    Ludwig D; Carter J; Smith JR; Borsani G; Barlati S; Hafizi S
    BMC Med Genet; 2013 Jun; 14():65. PubMed ID: 23809228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of tensin3 in mice results in growth retardation and postnatal lethality.
    Chiang MK; Liao YC; Kuwabara Y; Lo SH
    Dev Biol; 2005 Mar; 279(2):368-77. PubMed ID: 15733665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of the adenomatous polyposis coli gene in sporadic thyroid neoplasms.
    Zeki K; Spambalg D; Sharifi N; Gonsky R; Fagin JA
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1317-21. PubMed ID: 7962323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
    Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of APC mRNA in human tissues.
    Schnitzler M; Dwight T; Marsh DJ; Gaskin EL; Robinson BG
    Biochem Biophys Res Commun; 1995 Dec; 217(2):385-92. PubMed ID: 7503712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid transcription factor-1 in normal, hyperplastic, and neoplastic follicular thyroid cells examined by immunohistochemistry and nonradioactive in situ hybridization.
    Katoh R; Kawaoi A; Miyagi E; Li X; Suzuki K; Nakamura Y; Kakudo K
    Mod Pathol; 2000 May; 13(5):570-6. PubMed ID: 10824930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias.
    Chiappetta G; Ferraro A; Vuttariello E; Monaco M; Galdiero F; De Simone V; Califano D; Pallante P; Botti G; Pezzullo L; Pierantoni GM; Santoro M; Fusco A
    Eur J Cancer; 2008 May; 44(7):1015-21. PubMed ID: 18375116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms.
    Nicolussi A; D'Inzeo S; Mincione G; Buffone A; Di Marcantonio MC; Cotellese R; Cichella A; Capalbo C; Di Gioia C; Nardi F; Giannini G; Coppa A
    Int J Oncol; 2014 Feb; 44(2):548-56. PubMed ID: 24316730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.